Hot Pursuit     19-Jun-23
Biocon Ltd spurts 0.71%, rises for fifth straight session
Biocon Ltd is quoting at Rs 246.65, up 0.71% on the day as on 12:44 IST on the NSE. The stock is down 21.97% in last one year as compared to a 22.35% spurt in NIFTY and a 12.59% spurt in the Nifty Metal.

Biocon Ltd gained for a fifth straight session today. The stock is quoting at Rs 246.65, up 0.71% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.24% on the day, quoting at 18781.15. The Sensex is at 63246.52, down 0.22%. Biocon Ltd has risen around 2.58% in last one month.

Meanwhile, Nifty Metal index of which Biocon Ltd is a constituent, has risen around 8.95% in last one month and is currently quoting at 13241.95, up 0.74% on the day. The volume in the stock stood at 13.41 lakh shares today, compared to the daily average of 37.81 lakh shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 247.05, up 0.45% on the day. Biocon Ltd is down 21.97% in last one year as compared to a 22.35% spurt in NIFTY and a 12.59% spurt in the Nifty Metal index.

The PE of the stock is 281.55 based on TTM earnings ending March 23.

Previous News
  Biocon reports consolidated net profit of Rs 660.00 crore in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   07:41 )
  Biocon gets US FDA nod for fungal infection drug
 ( Hot Pursuit - 04-Jun-24   11:18 )
  Biocon Biologics set to introduce YESAFILI®, a proposed biosimilar to EYLEA® in Canadian market
 ( Corporate News - 04-Mar-24   09:30 )
  Biocon Ltd spurts 4.01%, rises for fifth straight session
 ( Hot Pursuit - 26-Apr-24   13:00 )
  Biocon Ltd rises for third straight session
 ( Hot Pursuit - 15-Feb-24   13:05 )
  Biocon CFO resigns
 ( Corporate News - 08-Feb-24   19:43 )
  Biocon Ltd soars 0.15%, up for fifth straight session
 ( Hot Pursuit - 20-Jul-23   13:00 )
  Biocon Ltd up for third consecutive session
 ( Hot Pursuit - 01-Dec-23   13:05 )
  Biocon
 ( Results - Analysis 28-Jul-22   10:30 )
  Biocon Biologics update on USFDA's CRL issued to partner Viatris (Mylan)
 ( Corporate News - 13-Feb-23   09:20 )
  Insulin Glargine to be offered by Walgreens Prescription Savings Club
 ( Corporate News - 19-Nov-21   10:50 )
Other Stories
  RVNL gains on emerging as L-1 bidder for Rs 133-cr railway project
  03-Jul-24   15:38
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
Back Top